What is Ciplox tablet (ciprofloxacin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ciplox tablet kya hai?

Ciplox ek ciprofloxacin wali fluoroquinolone antibiotic tablet hai, jo sirf gambhir ya uchch-jokhim bakteriayi infections (jaise pyelonephritis/upper UTI, prostatitis, tularemia, anthrax PEP) mein, jab behtar vikalp upyukt na hon, tab istemal karni chahiye—kyunki isse gambhir side-effects aur resistance ka khatra badhta hai. 1, 2, 3, 4, 5

  • Gharai se samjhein:
    • Drug/class: Ciprofloxacin (fluoroquinolone) oral tablets 250/500/750 mg; brand: Ciplox. 1
    • FDA/Label safety: Tendon rupture/tendinitis, neuropa­thy, CNS effects, QT prolongation, hypoglycemia; bachchon mein pehli pasand nahi; tizanidine ke saath mana. 1

Kab istemal karein (morbidity–mortality–QOL ko dhyan mein rakhkar)

  • Pyelonephritis ya prostatitis (mild–moderate), agar local fluoroquinolone resistance ≤10% ho: ciprofloxacin preferred; warna pehle ek IV long-acting dose (jaise ceftriaxone) dekar tailor karein. 3, 2
  • Tularemia: CDC (2025) ke mutabik ciprofloxacin first-line effective vikalp. 4
  • Inhalational anthrax post-exposure prophylaxis: ciprofloxacin 500 mg BID 60 din tak (vaccine ke saath). 5

Kab na dein / saavdhaniyan

  • Asaan lower UTI (cystitis) ke liye pehli pasand nahi; nitrofurantoin/AMC/TMP-SMX ko tarjeeh. Fluoroquinolones ko reserve rakhein taaki resistance aur serious AEs kam hon. 3, 2
  • Bachche (<18 saal): sirf vishesh gambhir indications (complicated UTI/anthrax PEP). 1
  • Pregnancy/breastfeeding: anthrax PEP mein chal sakta hai; anya sthitiyon mein risk–benefit sakht nazar se. 5
  • Tizanidine ke saath bilkul na dein; steroids/umr >60/tendon history mein tendon rupture ka zyada khatra. 1
  • High local FQ resistance (>10% UTI pathogens) ho to monotherapy se bachien. 3

Typical dosing (adult)

  • Pyelonephritis/prostatitis (outpatient, resistance ≤10%): 500 mg PO 12-hourly 7 din (ER 1000 mg OD 7 din bhi viklap). Agar resistance >10% sandigdh ho to shuruaat mein 1 g ceftriaxone IV ek baar. 3
  • Tularemia: 750 mg PO 12-hourly (guideline doses per CDC). 4
  • Anthrax PEP: 500 mg PO 12-hourly, 60 din. 5

Aam pitfalls aur unse bachav

  • Uncomplicated cystitis mein jaldi se FQ shuru kar dena—isse resistance/QOL harm badhta hai; pehle narrow-spectrum agents chunen. 3, 2
  • Tizanidine co-use, dairy/antacids/iron ke saath dena (absorption ghatta hai); dose se 2–4 ghante alag rakhen. 1
  • Tendon dard/soojan ko ignore na karein—turant band karein aur vikalp antibiotic par switch karein. 1

Evidence strength and recency:

  • WHO 2024 AWaRe: upper UTI/prostatitis mein ciprofloxacin first-choice (agar AMR allow kare), lower UTI ke liye nahi. 2
  • IDSA/ESCMID 2011: pyelonephritis mein ciprofloxacin effective; cystitis mein FQ ko reserve rakhen. 3
  • CDC 2025 tularemia: ciprofloxacin first-line supported. 4
  • FDA Label 2026: safety contraindications/warnings definitive. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.